BioCryst Pharmaceuticals Inc. (BCRX)

1.59
0.20 11.00
NASDAQ : Health Technology
Prev Close 1.79
Open 1.61
Day Low/High 1.51 / 1.73
52 Wk Low/High 1.76 / 9.95
Volume 5.81M
Avg Volume 1.44M
Exchange NASDAQ
Shares Outstanding 110.44M
Market Cap 210.94M
EPS -1.00
P/E Ratio N/A
Div & Yield N.A. (N.A)
'Mad Money' Lightning Round: GE Is a Good Stock With Good Yield

'Mad Money' Lightning Round: GE Is a Good Stock With Good Yield

Cramer is skittish on Sanofi, can't recommend C&J Energy Services and doesn't want you in Annaly Capital.

Jim Cramer's 'Mad Money' Recap: Why This Market Is All About Velocity

Jim Cramer's 'Mad Money' Recap: Why This Market Is All About Velocity

A day's rest from the selling in oil will allow investors, analysts and oil companies themselves some time to assess their situations, Cramer says.

December's Essential, Stock-Moving Biotech Events Explained While Eating Turkey

December's Essential, Stock-Moving Biotech Events Explained While Eating Turkey

A cheat sheet of earnings, medical meetings, FDA approval decisions and clinical trial results for health care investors.

BCRX Crosses Below Key Moving Average Level

BCRX Crosses Below Key Moving Average Level

In trading on Wednesday, shares of BioCryst Pharmaceuticals, Inc. crossed below their 200 day moving average of $11.03, changing hands as low as $10.88 per share.

Ebola Linked Names Rise Again Amid Broader Market Sell-Off

Ebola Linked Names Rise Again Amid Broader Market Sell-Off

Shares of companies leveraged to Ebola are rising again after a second health care worker in the U.S. tested positive for the illness.

Strong On High Relative Volume: Biocryst Pharmaceuticals (BCRX)

Strong On High Relative Volume: Biocryst Pharmaceuticals (BCRX)

Trade-Ideas LLC identified Biocryst Pharmaceuticals (BCRX) as a strong on high relative volume candidate

Lakeland Industries Continues To Surge Amid Ebola Fears

Lakeland Industries Continues To Surge Amid Ebola Fears

Shares of Lakeland Industries, which supplies protective clothing to the Centers for Disease Control and other governmental agencies, are soaring amid continued fears over the Ebola outbreak...

Ebola Outbreak Puts the Spotlight on 10 Biotech Companies

Ebola Outbreak Puts the Spotlight on 10 Biotech Companies

The Ebola outbreak has put the spotlight on Chimerix as well as other biotech companies with potential vaccines and even those stocks with marginal relation to the virus.

Perilous Reversal Stock: Biocryst Pharmaceuticals (BCRX)

Perilous Reversal Stock: Biocryst Pharmaceuticals (BCRX)

Trade-Ideas LLC identified Biocryst Pharmaceuticals (BCRX) as a "perilous reversal" (up big yesterday but down big today) candidate

Biocryst Pharmaceuticals (BCRX) Marked As A Barbarian At The Gate

Biocryst Pharmaceuticals (BCRX) Marked As A Barbarian At The Gate

Trade-Ideas LLC identified Biocryst Pharmaceuticals (BCRX) as a "barbarian at the gate" (strong stocks crossing above resistance with today's range greater than 200%) candidate

Why You Should Stay Away From the Ebola Frenzy in Biotech Stocks

Why You Should Stay Away From the Ebola Frenzy in Biotech Stocks

Ebola lands in Texas, so expect some crazy volatility Wednesday in biotech and drug stocks.

Heavy Early Morning Activity On Biocryst Pharmaceuticals (BCRX)

Heavy Early Morning Activity On Biocryst Pharmaceuticals (BCRX)

Trade-Ideas LLC identified Biocryst Pharmaceuticals (BCRX) as a pre-market mover with heavy volume candidate

Strong On High Relative Volume: Biocryst Pharmaceuticals (BCRX)

Strong On High Relative Volume: Biocryst Pharmaceuticals (BCRX)

Trade-Ideas LLC identified Biocryst Pharmaceuticals (BCRX) as a strong on high relative volume candidate

BioCryst Pharmaceuticals is Now Oversold (BCRX)

BioCryst Pharmaceuticals is Now Oversold (BCRX)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Trade Ebola Stocks? Sure, But Don't Bet on Big Business Opportunity

Trade Ebola Stocks? Sure, But Don't Bet on Big Business Opportunity

The Ebola outbreak in West Africa is a public health emergency which has also captured the attention of U.S. investors (perhaps I should say traders.)

TheStreet Quant Rating: D- (Sell)